6 Incredible Reasons to Invest in Eli Lilly
The drug giant’s winning ways look set to continue for a while.
Mindfully Curated
The drug giant’s winning ways look set to continue for a while.
These stocks all trade at less than 14 times their expected future profits.
Is Apple’s strategy to launch Apple Intelligence wise? This week, Autonomous Technology and Robotics Director of Research Sam Korus and Associate Portfolio Manager Nick Grous are joined by ARK Research Associate Jozef Soja to discuss Replit and updates…
The smart-TV pioneer has been soaring since hitting an 18-month low last month.
One bank tracking the company has flagged it as a top play in its sector.
If you’re living in one of these states, you might want to consult a professional to help you keep more of your Social Security benefits.
The biotech continues to earn important wins, but is it enough?
Some unusual news from across the Pacific Ocean combined with a bullish new analyst take to make the company a hot item with investors.
The growing use of AI systems could supercharge demand for the wares of chipmakers Broadcom and Arm Holdings.
XRP could be ready for a major comeback. Here are three good reasons why.
Alphabet can now provide investors with both income and growth.
The size of the dividend for Warren Buffett’s company, Berkshire Hathaway, might surprise you.
These boring stocks beating Nvidia in 2025 isn’t as far-fetched as it might sound.
Why DocuSign could be poised to rally.
These players have had their ups and downs — but the future looks bright.
After years of turmoil, AT&T has been making strides to return to its roots — and it seems to be paying off.
Does a great brand always go hand in hand with a great stock?
The electronics giant is focusing on entertainment sales, but there’s a catch to owning shares.
The proverbial planets are aligning, even if most investors don’t see it yet.
Tesla stock still has the potential to become a multibagger.